Verma

What Verma does

Verma Drugs (Verma S.A.) is a Greek pharmaceutical and MedTech company founded in 1978-1979 by chemist and pharmacist Komninos Gamvroulis, headquartered in Koropi, Attica. The company specializes in renal care and operates three product pillars: hemodialysis (concentrates, sodium bicarbonate cartridges/bags, VERMAFIL and Asahi REXEED dialyzers, VermaClean disinfectants), peritoneal dialysis (Vermalin solutions, PD VermaCap disposables, Cycler SmartPD automated system), and intensive care (Dianova X2 CRRT machine, Vermalton CRRT fluids, Efferon LPS extracorporeal adsorber for sepsis). The R&D team holds six patents, primarily around proprietary dialysis concentrate formulations incorporating citric acid and L-Ascorbic Acid variants that claim reductions in heparin usage, thrombosis episodes, and oxidative stress. Manufacturing takes place at a 7,000 m² state-of-the-art facility in Koropi operating under GMP (since 1998), ISO 13485, and CE mark certifications (CE 0476 for VERMAFIL, CE 2803 for PD VermaCap, plus the April 2024 EU MDR CE mark for Efferon LPS).

Verma operates a multi-channel B2B business model spanning direct sales to Greek hospitals and dialysis clinics, international exports (with named distribution partners including Terumo since 1992, Asahi Rexeed since 2001, Dialife since 2019, and Efferon since 2024), OEM/white-label manufacturing for international clients, third-party manufacturing services, and representation of foreign medical technology companies in the Greek market. The company also runs Polyxenia Renal Clinic, a wholly-owned flagship 24/7 hemodialysis unit in Koropi, extending the model into direct patient care services. Customer segments include hospitals and dialysis clinics (primary), renal patients and healthcare professionals (persona-level), international healthcare companies (for OEM), and academic research institutions (for oncology co-development).

Geographically, Verma serves Greece and Serbia with confirmed distribution, and claims global export reach. Revenue is not publicly disclosed, and the company is privately held with no parent entity. Strategic investments in 2019 (Newsol, Dialife) and a 2021 EU NSRF 'SME Extraversion' grant indicate capital backing for internationalization and technology modernization. The company is actively operating with a continuous product launch cadence (VermaClean 2016, VermaCitra/CitraVit/Verma-C 2017, PD VermaCap 2021, DEMO concentrates 2022, Efferon LPS 2024) and ongoing R&D into oncology adjacencies.

Name

Verma

Legal name

Verma S.A.

Website

https://verma.gr

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

11–50 employees

Short description

Verma Drugs is a Greek pharmaceutical and MedTech company specializing in renal care, manufacturing hemodialysis concentrates, dialyzers, CRRT machines, and peritoneal dialysis products for hospitals, dialysis clinics, and international OEM partners, with vertical integration into patient care through Polyxenia Renal Clinic.

Ownership category

akta.pro rank

Product category

Renal Care Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH)

akta.pro secondary industries

Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Dialyzers (Artificial Kidneys) (HLAHAKAC), Renal Care Ancillaries (Anemia Management Devices, Phosphate Binder Support, Nutrition Monitoring) (HLAHAKAK), Hemodialysis Machines & Systems (HLAHAKAA), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

Keywords

• Hemodialysis concentrates
• Peritoneal dialysis solutions
• Dialysis medical devices
• Renal care products
• CRRT machines

Headquarters

HQ city

Koropí

HQ country

Greece

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Dialysis Products Manufacturing and Sales: Manufacturing and sale of hemodialysis products including concentrates, dialyzers, bicarbonate cartridges/bags, disinfectants, and peritoneal dialysis solutions for hospital use in Greece and international markets.
2. Third-Party Manufacturing Services: Offering manufacturing capabilities to other companies, allowing partners to optimize production processes while Verma handles manufacturing complexities. Also includes OEM production of finished products under client brand names.
3. Representation of International Companies: Partnership with global healthcare leaders to introduce innovative products and technologies to the Greek market through strategic alliances.
4. Polyxenia Renal Clinic Services: Flagship hemodialysis unit providing 24/7 patient care services in a state-of-the-art facility in Koropi, Attica.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Verma (Verma Drugs S.A.) manufactures and sells dialysis and renal care products including hemodialysis concentrates, sodium bicarbonate cartridges and bags, dialyzers, peritoneal dialysis solutions, CRRT machines, and extracorporeal blood purification devices. The company also operates the Polyxenia Renal Clinic hemodialysis unit and offers OEM/third-party manufacturing services for international healthcare partners.

Product overview

Verma is a Greek pharmaceutical and MedTech company specializing in renal care solutions. The product portfolio is organized into three main categories: Hemodialysis products (including dialysis concentrates, sodium bicarbonate cartridges/bags, dialyzers, disinfectants, and Dianova hemodialysis machines), Peritoneal Dialysis products (Vermalin solutions, PD VermaCap disposables, and Cycler SmartPD automated cycler), and Intensive Care products (Dianova X2 CRRT machine, Vermalton CRRT fluids, and Efferon LPS extracorporeal adsorber). Verma also offers specialized concentrate formulations enhanced with L-Ascorbic Acid and Citric Acid for improved therapeutic outcomes. The company provides OEM manufacturing services, technical support, and patient support programs. Products are manufactured in Greece and Italy under GMP, ISO 13485, and European Pharmacopoeia standards, with global distribution through strategic partnerships.

Differentiator

Problem solved

Functional benefit

Brands

• Vermalin: Peritoneal dialysis solutions for automated and manual peritoneal dialysis
• VermaCap
• Vermalton
• Verma-C
• VermaCitra
• CitraVit
• VermaClean
• Verma-Cart
• Verma-Bag
• Verma-Ci-Cart
• Verma-Ci-Bag
• VERMAFIL
• Dianova
• SmartPD
• Vermasol

Products and services

• Dialysis Concentrates Dialysis concentrates designed for compatibility with all types of dialysis machines, available in various compositions to facilitate removal of toxic substances from blood while replenishing electrolytes lost during haemodialysis sessions. Pyrogen-free, tested for endotoxins and aluminium. Intended for hospitals and dialysis clinics.
• Verma-Cart & Verma-Bag Series Sodium bicarbonate cartridges and bags designed for continuous preparation of alkaline dialysis solutions. Feature particle-retaining filters, transparent packaging for monitoring, and 100% recyclable eco-friendly materials. Compliant with European Pharmacopoeia.
• Verma-Ci-Cart & Verma-Ci-Bag Series Sodium bicarbonate cartridges and bags with citric acid as pH-regulating agent. Anhydrous citric acid quickly stabilizes dialysate pH from session onset, reducing priming time and preventing unwanted machine alarms. Eco-friendly, made in Greece.
• VERMAFIL LX/HX Dialyzers Dialyzers featuring enhanced fiber design with optimized geometry and packing density. BPA-free construction ensures maximum fiber usage, increased strength, and improved flow dynamics. Complies with CE 0476 under UNI CEI EN ISO 13485-2016.
• Asahi REXEED Dialyzers Dialyzers with advanced membrane technology featuring sharp cut-off curve for selective removal of low molecular weight proteins while retaining albumin. Gamma-sterilized wet-type dialyzers with optimal biocompatibility. Distributed by Verma in Greece.
• VermaClean Series Comprehensive cleaning and disinfection products for fluid paths in dialysis machines. Effectively remove calcium salts, organic deposits, proteins, and fats. Non-corrosive, eco-friendly, significantly reduces biofilm formation, and allows simultaneous decalcification and disinfection.
• Verma-C Concentrates Specialized haemodialysis concentrates enhanced with L-Ascorbic Acid offering oxidative stress management, anti-inflammatory benefits, and stabilization of vitamin C levels. Adheres to European Pharmacopoeia standards.
• VermaCitra Concentrates Specialized acidic dialysis concentrates with citric acid that reduce thrombosis episodes, decrease heparin usage, and enhance filter functionality. Provides improved acidosis management, hemodynamic stability, and compliance with European Pharmacopoeia.
• CitraVit Concentrates Acid citrate dialysis concentrates featuring L-Ascorbate providing optimized anticoagulation, reduced thrombotic risk, oxidative stress mitigation, and enhanced haemodynamic response. Formulated for personalized dialysis care.
• Dianova Hemodialysis Machines Advanced hemodialysis systems engineered for ONLINE hemodialysis. Feature user-friendly interface, automated functionalities, enhanced safety standards, precise ultrafiltration control, and cost-effective non-patented consumables. Exclusively available in Greece.
• Dianova X2 CRRT Machine Continuous Renal Replacement Therapy machine with flat rotating 15-inch touch screen, automated online priming, heparin pump with multiple syringe size detection, and dual ultrasonic/optical air detection. Offers therapies including hemodialysis, hemofiltration, hemoperfusion, and online hemodiafiltration.
• Vermalin Peritoneal Dialysis Solutions Peritoneal dialysis solutions designed for automated and manual peritoneal dialysis. Safe, user-friendly, restores electrolyte balance, corrects metabolic acidosis. Sterile, pyrogen-free, exclusively produced for Verma Drugs.
• PD VermaCap Peritoneal dialysis disposable cap with povidone-iodine ensuring easy connection and disconnection, minimizing peritonitis risk. CE marked (CE 2803), Luer-Lock compatible, made in Greece.
• Cycler SmartPD Automated PD System Automated Peritoneal Dialysis cycler offering safe and efficient APD solution for patients of all ages including pediatric patients. Features automated operations (IPD, CCPD, NPD, Tidal PD), continuous pressure monitoring, intuitive color touch screen, and inline solution heating.
• Vermalton CRRT Fluids CRRT fluids for hemodialysis, hemofiltration, and hemodiafiltration. Dual-chamber composition of bicarbonate and lactate provides balanced electrolyte and plasma replenishment. Sterile, pyrogen-free, aluminium-free, produced in Italy under EU standards.
• Efferon LPS Extracorporeal Adsorber Single-use extracorporeal adsorber for sepsis treatment and multiple organ failure syndrome. Achieved CE mark approval under EU MDR in April 2024. Selectively removes bacterial endotoxins and cytokines through advanced polymeric adsorbents.
• OEM Manufacturing Services OEM manufacturing services offering custom manufacturing of products tailored to specifications or supplying finished pre-designed products under customer brand names. Product range includes dialysis concentrates, citrate dialysis concentrates, bicarbonate cartridges/bags, decalcification agents, and VERMA-CAP disinfectant caps.
• Polyxenia Renal Clinic Verma's flagship hemodialysis unit in Koropi, Attica. State-of-the-art facility equipped with latest technology, providing 24/7 patient support in secure modern environment with focus on integrated patient-centric care.

Quantifiable outcome

• Reduction in thrombosis episodes during dialysis sessions
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

13 partnerships are on record, tiered core and minor.

• EfferoncoreTechnology or Integration · 1 January 2024Founded in 2016, Efferon specializes in extracorporeal blood purification technologies. Their Efferon LPS device achieved CE mark under EU MDR in April 2024 for sepsis treatment. Verma represents this product in Greece.
• KK FarmaminorChannel Partner/ Reseller/ Distributor · 1 January 2023Enhanced export activities through partnership established in 2023
• IperborealminorChannel Partner/ Reseller/ Distributor · 1 January 2023Partnership for export activities expansion established in 2023
• AritiminorChannel Partner/ Reseller/ Distributor · 1 January 2019B2B partnership expansion activities in 2019 for regional distribution
• AlkaloidminorChannel Partner/ Reseller/ Distributor · 1 January 2019B2B partnership expansion activities in 2019 for market access
• NewsolcoreStrategic or Co-development Partner · 1 January 2019Strategic investment in 2019 for expanded production capabilities and market reach
• DialifecoreStrategic or Co-development Partner · 1 January 2019Strategic investment in 2019 for DIANOVA hemodialysis and CRRT machines distribution. Dialife produces DIANOVA X2 CRRT machines.
• EcotrademinorChannel Partner/ Reseller/ Distributor · 1 January 2018Partnership in Serbia established 2018 for market expansion in the Balkans region
• HbiofluidsminorStrategic or Co-development Partner · 1 January 2007Collaboration for Vermathen brand products (2007) and Vermalin and Vermalton brand products (2008)
• Asahi RexeedcoreTechnology or Integration · 1 January 2001Collaboration since 2001 for Asahi Rexeed Dialyzers distribution in Greece. Products feature advanced membrane technology for optimal dialysis performance.
• MedionicsminorStrategic or Co-development Partner · 1 January 2000Partnership established in 2000 for dialysis technology products
• TerumocoreStrategic or Co-development Partner · 1 January 1992Strategic partnership formed in 1992 for dialysis products distribution in Greek market
• Leading Academic InstitutionsminorStrategic or Co-development PartnerCollaboration with leading academic institutions in R&D for co-developing cutting-edge oncology products

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Others

• Diaverum: One of the largest independent dialysis service providers worldwide, operating clinics across Europe, Latin America, and MEA. Comparable to Verma's Polyxenia Renal Clinic model as a service-side competitor in renal care delivery.

Broad incumbents

• Terumo: Long-standing Verma partner (since 1992) and major MedTech incumbent producing blood management, dialysis, and apheresis products. Strategic supplier/partner rather than direct Greek-market competitor, but its broader portfolio overlaps end-to-end with Verma's distribution focus.
• Baxter International: Dominant player in peritoneal dialysis (PD) solutions and systems globally (e.g., HomeChoice, Amia cyclers). Competes with Verma's Vermalin PD solutions and Cycler SmartPD across both consumables and APD equipment.
• Fresenius Medical Care: Global leader in dialysis products, services, and renal pharmaceuticals. Operates the largest installed base of HD machines and dialyzer production worldwide, dwarfing Verma's product breadth and geographic coverage.
• B. Braun: Full-portfolio dialysis manufacturer covering HD machines (Dialog), dialyzers, concentrates, and CRRT (Omni). Highly comparable product architecture to Verma's HD/PD/CRRT trinity with much larger scale.

Direct peers

• Nikkiso: Japanese maker of HD machines, CRRT systems, and dialyzers with established European and emerging-market presence. Competes head-to-head with Verma/Dialife's Dianova platforms in the CRRT and HD machine segment.
• Asahi Kasei Medical: Manufacturer of the Asahi REXEED dialyzer family distributed by Verma in Greece. Closely comparable as a dialyzer-focused medical device producer with membrane technology differentiation overlapping Verma's VERMAFIL line.
• Nipro Corporation: Japanese manufacturer of dialyzers, HD machines, and PD solutions with strong European distribution. Closest competitor to Verma in dialysis consumables, particularly in emerging markets where price-sensitive tenders favor Nipro or Verma.
• Dialife SA: Italian dialysis equipment maker and Verma's strategic partner (since 2019), producer of DIANOVA X2 CRRT machines distributed by Verma in Greece. Highly comparable as a niche European dialysis device specialist, though with broader EU direct-sales reach.

Emerging players

• JMS Co. Japanese manufacturer specializing in dialysis concentrates, blood tubing sets, and IV solutions, with growing European footprint. Direct peer to Verma's concentrates/bloodlines business, especially in private-label/OEM contexts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xlinkedin.com/company/verma-drugs
• LinkedInlinkedin.com/company/verma-drugs

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Verma